Gifford Bioscience Limited

Gifford Bioscience Limited specializes in receptor-ligand interactions through laboratory-based contract research services. The company offers a wide range of services including fee-for-service radioligand binding assays, functional assays, receptor occupancy studies, autoradiography, and SPR for clients in the pharmaceutical, biotech, and academic research sectors globally. Utilizing radiometric methods, fluorescence detection, and label-free kinetic affinity techniques, Gifford Bioscience conducts assays employing human and animal tissues, cultured cells, membranes, and recombinant proteins. Their expertise, garnered from years of experience, enables them to collaborate with clients in assay design and issue resolution.

Established in 2017, the company operates out of The BioHub Birmingham, a life science cluster on the University of Birmingham's research park. Gifford Bioscience serves the biotechnology, pharmaceutical, and marketing industries. While specific investment details are not available, the company's innovative approach and specialized services position it within the dynamic landscape of bioscience research and development, making it an intriguing prospect for potential venture capital opportunities.